AnalystsKumaraguru Raja
Kumaraguru Raja's Stock Forecasts

Analyst Ranking
Bottom 1%
#4202 out of 4241 analysts
Average Return
Win Rate
7%1 out of 14
Risk vs Reward

Kumaraguru Raja's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Atyr Pharma IncLIFE
2023-03-06 -
Strong Buy

Kumaraguru Raja Analyst Color

Get additional color on Kumaraguru Raja's coverage of popular stocks

Kumaraguru Raja's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Atyr Pharma IncLIFE
1Strong Buy$9.00+309.09%Reinstates
3 months ago
Rain Oncology IncRAIN
1Strong Buy$21.00+1,607.32%Reinstates
4 months ago
Apexigen IncAPGN
1Strong Buy$15.00+3,057.89%Reinstates
5 months ago
Monopar TherapeuticsMNPR
2Strong Buy$18.00+1,814.89%Reinstates
6 months ago
Veru IncVERU
1Strong Buy$31.00N/AMaintains
a year ago
Adial Pharmaceuticals IncADIL
1Strong Buy$12.00N/AInitiates Coverage On
2 years ago
Dermata Therapeutics IncDRMA
1Strong Buy$224.00N/AInitiates Coverage On
2 years ago
Oncternal Therapeutics IncONCT
1Strong Buy$16.00N/AInitiates Coverage On
2 years ago
9 Meters Biopharma IncNMTR
1Strong Buy$120.00N/AAssumes
2 years ago
Nls Pharmaceutics LtdNLSP
1Strong Buy$12.00N/AInitiates Coverage On
2 years ago
Lisata Therapeutics IncLSTA
1Strong Buy$10.00N/AMaintains
2 years ago
Cns Pharmaceuticals IncCNSP
1Strong Buy$300.00N/AInitiates Coverage On
2 years ago
Forte Biosciences IncFBRX
1Strong Buy$90.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.